Algeria
Egypt
Israel
Jordan
Lebanon
Libya
Morocco
Palestine *
Syria *
TunisiaEBRD and EU support greening of Morocco’s pharmaceutical sector
The EBRD is supporting Morocco’s pharmaceutical private sector with a MAD 380 million (€34.5 million) loan to Dislog Group companies, owned by H&S Holding (“H&S”), a diversified industrial Moroccan group operating in various areas of activity.
The facility to Dislog will consist of two tranches. MAD 270 million (€24.5 million) will be used to acquire Steripharma, a local pharmaceuticals manufacturer that provides affordable specialty generics medicines to replace expensive original products in the treatment of life-threatening diseases.
The remaining €10 million loan will finance the construction of a new green-certified industrial building and logistics platform as well as the installation of photovoltaic (PV) panels. The new PV panels are expected to generate energy to power the building and will help reduce CO2 emissions. This tranche will be supported by a guarantee from the European Union (EU) through its European Fund for Sustainable Development (EFSD), in line with the objective of the EU-Morocco Green Partnership.
The investment will enable Dislog to expand into the pharmaceuticals industry and capture higher added value in the supply chains in Morocco. The acquisition of Steripharma will complement Dislog’s established competence in reaching a wide network of small distribution outlets and help increase profit from its existing distribution channels and logistics chains.
Countries covered:
-
Morocco
